Boehringer Ingelheim News
Enterisol® Ileitis approved in Australia - first live swine vaccine ever in this marketAUSTRALIA - Boehringer Ingelheim Animal Health GmbH, announced today that the Australian regulatory authorities have granted market authorization for the porcine live vaccine Enterisol® Ileitis. Enterisol®...
Boehringer Donates PRRS Risk Assessment Program To IndustryUS - Boehringer Ingelheim Vetmedica, Inc., last week transferred ownership of its Risk Assessment Program for porcine reproductive and respiratory syndrome (PRRS) to the American Association of swine Veterinarians...
New Research Program Targets Porcine CircovirusUS - Porcine Circovirus Associated Diseases (PCVAD) such as PMWS and PDNS have been wreaking havoc in Europe for a number of years now, and are becoming a growing threat to the North American industry....
Swine practice: Marked increase in performance after ileitis vaccinationEU - Since the launch of Boehringer's ileitis vaccine "Enterisol® Ileitis" in most European countries from September to November 2005, the oral ileitis vaccine has very quickly become firmly established...
Four million piglets benefit from oral ileitis vaccineGERMANY - More than 4 million doses of Enterisol® Ileitis, the oral ileitis vaccine, have been supplied to German vets since the vaccine was launched...
New Ileitis vaccine produces dramatic performance lift, helps PMWSEU - In just four months, the use of a vaccine to control ileitis in a 550-sow herd has increased piglets’ average daily weight gain by 35%, cut mortality by more than 60% and improved the uniformity...
2006 PRRS Research Awards from BIVI Focus on Detection, Diagnostic ProtocolsMISSOURI - Research studies involving the transmission and monitoring of Porcine Reproductive and Respiratory Syndrome (PRRS) are the areas of concentration for the 2006 Advancement in PRRS Research Awards...
Boehringer Ingelheim offers combination discount for oral vaccines in USAUSA – Boehringer Ingelheim Vetmedica, Inc., (BIVI) have announced in the US they are offering a 20 percent discount from the list price on all orders of Ingelvac® ERY-ALC for control of swine erysipelas,...
Boehringer Ingelheim Expands Swine TeamUS - Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the promotion of Sara Balvanz to sales representative and the addition of Abby Lauenroth as corporate account trainer for the company’s swine...
US - Ingelheim/Germany, Copenhagen/Denmark, 13 January 2006 – Boehringer Ingelheim’s Natural Care Center (NCC) announced today that it will also be marketing two of its recent nutraceutical products...
MISSOURI - Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the addition of Chris Beard and Douglas Skartvedt as sales representatives for the company’s swine division. Both have more than 10...
MISSOURI - Boehringer Ingelheim Vetmedica, Inc. (BIVI) is offering swine producers diagnostic profiling services to protect pigs from porcine reproductive and respiratory syndrome (PRRS).
First vaccine for the control of porcine Ileitis now available across EuropeGERMANY - Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve...
UK - Just over eighteen months ago, Boehringer Ingelheim's Ingelvac M hyo vaccine hit the UK and Irish markets. This innovative product delivered a new immunity to enzootic pneumonia through a single...
GERMANY - Boehringer Ingelheim Animal Health has received two important label extensions from health care authorities for the vaccines Ingelvac® PRRS MLV and Ingelvac® M.hyo, which reflects the company’s...













© 2000 - 2012. 5m Publishing, Benchmark House, 8 Smithy Wood Drive, Sheffield, S35 1QN, England. - A Benchmark Holdings Ltd. Company